Literature DB >> 22396169

Physiology of FGF15/19.

Stacey A Jones1.   

Abstract

This chapter will review the various biological actions of the mouse fibroblast growth factor 15 (Fgf15) and human fibroblast growth factor 19 (FGF19). Unlike other members of the fibroblast growth factor (FGF) family, the Fgf15 and FGF19 orthologs do not share a high degree of sequence identity. Fgf15 and FGF19 are members of an atypical subfamily of FGFs that function as hormones. Due to subtle changes in tertiary structure, these FGFs have low heparin binding affinity enabling them to diffuse away from their site of secretion and signal to distant cells. FGF signaling through the FGF receptors is also different for this sub-family, requiring klotho protein cofactors rather than heparin sulfate proteoglycan. Mouse Fgf15 and human FGF19 play key roles in enterohepatic signaling, regulation of liver bile acid biosynthesis, gallbladder motility and metabolic homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396169     DOI: 10.1007/978-1-4614-0887-1_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  26 in total

1.  Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition.

Authors:  Benjamin Schmidt; Lan Wei; Danielle K DePeralta; Yujin Hoshida; Poh Seng Tan; Xiaochen Sun; Janelle P Sventek; Michael Lanuti; Kenneth K Tanabe; Bryan C Fuchs
Journal:  Int J Cancer       Date:  2015-11-09       Impact factor: 7.396

Review 2.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

Review 3.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

4.  Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

Authors:  Laurent Vergnes; Jessica M Lee; Robert G Chin; Johan Auwerx; Karen Reue
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

5.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Authors:  Marlene Wewalka; Mary-Elizabeth Patti; Corinne Barbato; Sander M Houten; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

Review 6.  FGF23 associated bone diseases.

Authors:  Eryuan Liao
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

Review 7.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

8.  Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions.

Authors:  Hongfei Ge; Jun Zhang; Yan Gong; Jamila Gupte; Jay Ye; Jennifer Weiszmann; Kim Samayoa; Suzanne Coberly; Jonitha Gardner; Huilan Wang; Tim Corbin; Danny Chui; Helene Baribault; Yang Li
Journal:  J Biol Chem       Date:  2014-09-09       Impact factor: 5.157

Review 9.  Beyond intestinal soap--bile acids in metabolic control.

Authors:  Folkert Kuipers; Vincent W Bloks; Albert K Groen
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

Review 10.  Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.

Authors:  Karen Reue; Jessica M Lee; Laurent Vergnes
Journal:  Curr Opin Lipidol       Date:  2014-04       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.